Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs IV Tranexamic Acid in Total Hip Arthroplasty
NCT04691362Phase 4Completed
- Sponsor
- University of Liège
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in postoperative hemorrhage (2 arms), sponsored by University of Liège. Primary endpoint: Total blood loss at 48 hours. Started Jan 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postoperative hemorrhage
Beyond the preview
Go deeper on NCT04691362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04691362.